Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Consort Medical plc
Consort Medical plc
Activities:
Manufacturing
Drug Delivery
Medical Devices
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Recipharm and Consort Medical agree takeover to integrate CDMO services
The Board of Consort has confirmed its unanimous intention to recommend a cash offer of US$652m for the acquisition
Manufacturing
Consort Medical backs Mylan in FDA approval for generic version of Advair
British CDMO has built a 5,500 sqm dedicated cleanroom at its King’s Lynn site to support production of the dry powder inhaler
Manufacturing
Consort Medical upgrades European facilities
Global CDMO invests in manufacturing and packaging capabilities for Aesica production plants in Italy and Germany
Media
Consort Medical signs agreement with Opiant Pharmaceuticals
Subsidiaries Bespak and Aesica will jointly develop, with the specialty pharmaceutical company, a ready-to-use nasal delivered version of nalmefene to treat opioid overdoses
Recruitment
CFO appointment for Consort Medical
Consort Medical announces that Paul Hayes, Group Finance Director of The Vitec Group, is to succeed Richard Cotton as Consort Medical’s Group Chief Financial Officer (CFO)
Drug Delivery
Consort Medical closes Syrina auto-injector master development agreement
Consort Medical is pleased to announce that Bespak has entered into a master development agreement including key commercial supply terms with a leading global biopharmaceutical company
Drug Delivery
Bespak signs new scale-up and commercial supply agreement
Pressurised metered dose inhaler technology will be used in respiratory devices to treat COPD
Subscribe now